Download PDF
Thromb Haemost 1992; 67(05): 491-493
DOI: 10.1055/s-0038-1648478
Editorial
Schattauer GmbH Stuttgart

Prevention of Post-Operative Thrombosis by Low Molecular Weight Heparin in Patients Undergoing Hip Replacement

Duncan P Thomas
Bio Products Laboratory, Elstree, Herts., U. K.
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

 

  • References

  • 1 Stamatakis JD, Kakkar W, Sagar S, Lawrence D, Naim D, Bentley PG. Femoral vein thrombosis and total hip replacement. Br Med J 1977; 2: 223-225
    CrossrefPubMedGoogle Scholar
  • 2 Sikorski JM, Hampson WG, Staddgn GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg (Br) 1981; 63: 171-177
    CrossrefPubMedGoogle Scholar
  • 3 Laverick MD, Croal SA, Mollan RAB. Orthopaedic surgeons and thromboprophylaxis. Br Med J 1991; 303: 549-550
    CrossrefPubMedGoogle Scholar
  • 4 Parker-Williams J, Vickers R. Major orthopaedic surgery on the leg and thromboembolism. Br Med J 1991; 303: 531-532
    CrossrefPubMedGoogle Scholar
  • 5 Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized controlled trial of a low-molecular weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-929
    CrossrefPubMedGoogle Scholar
  • 6 Eriksson BI, Zachrisson BE, Teger-Nilsson AC, Risberg B. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement. Br J Surg 1988; 75: 1053-1057
    CrossrefPubMedGoogle Scholar
  • 7 Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weill D, Butel J. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemostas 1988; 60: 407-410
    PubMedGoogle Scholar
  • 8 Dechavanne M, Ville D, Berruyer M, Trepo F, Dalery F, Clermont N, Lerat JL, Moyen B, Fischer LP, Kher A, Barbier P. Randomized trial of a low molecular weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep vein thrombosis after elective hip surgery. Haemostasis 1989; 1: 5-12
    PubMedGoogle Scholar
  • 9 Leyvraz PF, Bachmann F, Hoek J, Buller HR, Postel M, Samama M, Vandenbroek MC. Prevention of deep vein thrombosis after hip replacement: randomized comparison between imfractionated heparin and low molecular weight heparin. Br Med J 1991; 303: 543-548
    CrossrefPubMedGoogle Scholar
  • 10 Leyvraz PF, Richard J, Bachmann F. et al Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983; 309: 954-958
    CrossrefPubMedGoogle Scholar
  • 11 Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991; 114: 545-551
    CrossrefPubMedGoogle Scholar
  • 12 Nurmohamed MT, Buller HR, Dekker E, Hommes DW, ten Cate JW. The efficacy and safety of low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. In: Prevention of venous thromboembolism. Bergqvist D, Comerota A, Nicolaides A, Scurr J. eds Nicosia; London Los Angeles: Med-Orion: 1992. (in preparation)
    Google Scholar